Table 4.

Factors associated with presence of HCV viremia among 882 HIV-infected HCV-seropositive women at baseline WIHS visit, multivariate analysis^a

	Total no. of women	HCV-viremic (n, %)	OR (95% CI)b	p-Value c
Race
White	157	125 (80%)	1.0
Hispanic	172	126 (73%)	1.1 (0.6–1.9)	0.84
Black	534	460 (86%)	1.7 (1.0–2.8)	0.05
Others	19	12 (63%)	1.0 (0.2–4.2)	0.97
History of cocaine use
No	672	541 (81%)	1.0
Yes	208	180 (87%)	0.9 (0.5–1.6)	0.81
History of crack/freebase cocaine use
No	609	480 (79%)
Yes	271	241 (89%)	1.7 (1.0–3.0)	0.07
History of marijuana/hash use
No	641	517 (81%)	1.0
Yes	237	202 (85%)	1.2 (0.7–2.0)	0.44
History of blood transfusion
No	641	535 (83%)	1.0
Yes	156	123 (79%)	0.6 (0.4–1.0)	0.07
Alcohol use
0/wk	403	320 (79%)	1.0
<3/wk	182	152 (84%)	1.2 (0.7–2.0)	0.61
3–13/wk	155	127 (82%)	0.9 (0.5–1.6)	0.68
13+/wk	120	104 (87%)	1.1 (0.6–2.4)	0.71
Current smoking
No	213	155 (73%)	1.0
Yes	667	566 (85%)	1.9 (1.2–2.9)	0.005
HBV status
Seronegative	98	86 (88%)	1.0
Anti-HBs only	18	16 (89%)	0.9 (0.2–5.2)	0.93
Anti-HBc(+)/anti-HBs(+)	281	219 (78%)	0.5 (0.2–1.1)	0.09
Anti-HBC(+) only	307	263 (86%)	0.7 (0.3–1.7)	0.49
HBsAg(+)	31	19 (61%)	0.2 (0.1–0.5)	0.0017
HIV therapy
None	336	279 (83%)	1.0
Mono	287	240 (84%)	0.9 (0.6–1.6)	0.80
Combo	225	177 (79%)	0.7 (0.4–1.3)	0.31
HAART	32	25 (78%)	0.6 (0.1–6.3)	0.66
HIV plasma RNA (copies/ml)
≤4,000	275	209 (76%)	1.0
4,001–20,000	191	155 (81%)	1.3 (0.7–2.2)	0.37
20,001–55,000	113	92 (81%)	1.4 (0.7–2.6)	0.34
55,001–100,000	87	75 (86%)	1.8 (0.8–3.8)	0.16
>100,000	211	188 (89%)	3.5 (1.8–7.1)	0.0004
CD4 counts(cells/ml)
>500	251	195 (78%)	1.0
200–500	385	319 (83%)	1.1 (0.7–1.9)	0.66
<200	224	191 (85%)	1.1 (0.5–2.2)	0.81

^aModel includes all variables with P < 0.20 on univariate analysis

^bOdds ratio (95% confidence interval) from dichotomous logistic regression

^cP-values < 0.05 are bolded